Evidence map›Paper›PMID 26470805›Full record

ArticleAmerican journal of preventive medicine2016

Enrolling Minority and Underserved Populations in Cancer Clinical Research.

Sherrie F Wallington, Chiranjeev Dash, Vanessa B Sheppard, Tawara D Goode, Bridget A Oppong, Everett E Dodson, Rhonda N Hamilton, Lucile L Adams-Campbell

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Online-delivered resistance exercise intervention among racially diverse breast cancer survivors: Feasibility, acceptability, and exploratory outcomes of B-REP.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  4. Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Trial
  5. Long-term Diet and Biomarker Changes after a Short-term Intervention among Hispanic Breast Cancer Survivors: The ¡Cocinar Para Su Salud! Randomized Controlled Trial.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Trial
  6. Immigrant and Mistrust in the Healthcare Setting: A Thematic Review.Journal of immigrant and minority health · 2026
    Review
  7. Faith, Culture, and Cancer: A Qualitative Study Exploring Muslim Women's Perspectives on Clinical Trials in the United Kingdom.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Impact of Clinical Trial Design on Recruitment of Racial and Ethnic Minorities.Journal of cancer education : the official journal of the American Association for Cancer Education · 2024
    Article
  17. Article
  18. Article
  19. Future of Treatment of Adolescents and Young Adults With ALL: A Vision for Collaboration and Equity.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sherrie F WallingtonGeorgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia. Electronic address: slw49@georgetown.edu.
Chiranjeev DashGeorgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.
Vanessa B SheppardGeorgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.
Tawara D GoodeNational Center for Cultural Competence, Department of Pediatrics, Georgetown University Medical Center, Washington, District of Columbia.
Bridget A OppongGeorgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia; Georgetown University Medical Center, Department of Surgery, Washington, District of Columbia.
Everett E DodsonGeorgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.
Rhonda N HamiltonGeorgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.
Lucile L Adams-CampbellGeorgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Subproject 2: Verifying Information and Communication Technology and Outcomes P60MD006920 · NIMHD · GEORGETOWN UNIVERSITY · PI ADAMS-CAMPBELL, LUCILE LAUREN, KIDWELL, CHELSEA S · 2012 to 2016
$6.3M
An HPV Health Communication Randomized Controlled Trial InterventionK01CA155417 · NCI · GEORGETOWN UNIVERSITY · PI WALLINGTON, SHERRIE LEE · 2011 to 2015
$659k
NCI NIH HHS 5 K01 CA155417-05NCI NIH HHS K01 CA155417NCI NIH HHS P30 CA051008NCI NIH HHS P30CA51008NIMHD NIH HHS P60 MD006920NIMHD NIH HHS P60MD006920
6 · The paper itself

Abstract

Research suggests that community involvement is integral to solving public health problems, including involvement in clinical trials-a gold standard. Significant racial/ethnic disparities exist in the accrual of participants for clinical trials. Location and cultural aspects of clinical trials influence recruitment and accrual to clinical trials. It is increasingly necessary to be aware of defining characteristics, such as location and culture of the populations from which research participants are enrolled. Little research has examined the effect of location and cultural competency in adapting clinical trial research for minority and underserved communities on accrual for clinical trials. Utilizing embedded community academic sites, the authors applied cultural competency frameworks to adapt clinical trial research in order to increase minority participation in nontherapeutic cancer clinical trials. This strategy resulted in successful accrual of participants to new clinical research trials, specifically targeting participation from minority and underserved communities in metropolitan Washington, DC. From 2012 to 2014, a total of 559 participants enrolled across six nontherapeutic clinical trials, representing a 62% increase in the enrollment of blacks in clinical research. Embedding cancer prevention programs and research in the community was shown to be yet another important strategy in the arsenal of approaches that can potentially enhance clinical research enrollment and capacity. The analyses showed that the capacity to acquire cultural knowledge about patients-their physical locales, cultural values, and environments in which they live-is essential to recruiting culturally and ethnically diverse population samples.

Indexed as

Clinical Trials as TopicMinority GroupsNeoplasmsPatient SelectionVulnerable PopulationsBlack or African AmericanBlack PeopleCommunity-Based Participatory ResearchCultural CompetencyDistrict of ColumbiaEthnicityFemaleHealth Services AccessibilityHealth Status DisparitiesHumansMale

Identifiers

PMID26470805
PMCPMC4691547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.